Article
Variants in CYP2J2 and CYP2C9 Contribute to Susceptibility of Lung Cancer.
Current cancer drug targets - 1 Jan 2025
Zhang Chan, Li Qi, Cheng Yujing, Yang Xin, Chen Wanlu, He Kunhua, Chen Mingwei
Abstract excerpt
BACKGROUND: Cytochrome P450 (CYP) enzymes are involved in the metabolism of xenobiotic and carcinogen. In the study, we evaluated the association of CYP2J2 and CYP2C9 variants with lung cancer. METHODS: Five polymorphisms in CYP2J2 and four polymorphisms in CYP2C9 were genotyped in 507 lung cancer patients and 505 controls with Agena MassARRAY platform. The linkage of variants with lung cancer risk was evaluated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
